prikaz prve stranice dokumenta To Treat or Not To Treat—From Guidelines to Individualized Patient Management
  Download
PDF 142.73 KB
Professional paper - Review paper
To Treat or Not To Treat—From Guidelines to Individualized Patient Management
Seminars in Hematology, 50 (2013); 12-17. https://doi.org/10.1053/j.seminhematol.2013.03.004
Matzdorff, Alex; Neufeld, Ellis J.; Roganović, Jelena

Cite this document

Matzdorff, A., Neufeld, E. J. & Roganović, J. (2013). To Treat or Not To Treat—From Guidelines to Individualized Patient Management. Seminars in Hematology, 50., 12-17. doi: 10.1053/j.seminhematol.2013.03.004

Matzdorff, Alex, et al. "To Treat or Not To Treat—From Guidelines to Individualized Patient Management." Seminars in Hematology, vol. 50, 2013, pp. 12-17. https://doi.org/10.1053/j.seminhematol.2013.03.004

Matzdorff, Alex, Ellis J. Neufeld and Jelena Roganović. "To Treat or Not To Treat—From Guidelines to Individualized Patient Management." Seminars in Hematology 50 (2013): 12-17. https://doi.org/10.1053/j.seminhematol.2013.03.004

Matzdorff, A., Neufeld, E. J. and Roganović, J. (2013) 'To Treat or Not To Treat—From Guidelines to Individualized Patient Management', Seminars in Hematology, 50, pp. 12-17. doi: 10.1053/j.seminhematol.2013.03.004

Matzdorff A, Neufeld EJ, Roganović J. To Treat or Not To Treat—From Guidelines to Individualized Patient Management. Seminars in Hematology [Internet]. 2013 [cited 2024 November 01];50:12-17. doi: 10.1053/j.seminhematol.2013.03.004

A. Matzdorff, E. J. Neufeld and J. Roganović, "To Treat or Not To Treat—From Guidelines to Individualized Patient Management", Seminars in Hematology, vol. 50, pp. 12-17, 2013. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:013751. [Accessed: 01 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)To Treat or Not To Treat—From Guidelines to Individualized Patient Management
AuthorAlex Matzdorff
AuthorEllis J. Neufeld
AuthorJelena Roganović
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Pediatrics)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Immune thrombocytopenia (ITP) is a rare disorder. Evidence-based guidelines provide important information for hematologists, as well as diagnostic and therapeutic recommendations to other physicians with limited expertise in the field. However, guidelines in pediatric and adult ITP do not answer some imperative questions: which patient is at risk of severe bleeding and requires pharmacologic treatment? Who will recover spontaneously? Is splenectomy still an appropriate second-line treatment for all chronic or persistent ITP patients? This review summarizes the current approach to these important issues, the patients’ perspective, and how we can improve individual patient management
Keywords (english)
Languageenglish
Publication typeProfessional paper - Review paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleSeminars in Hematology
Numberingvol. 50, pp. 12-17
p-ISSN0037-1963
DOIhttps://doi.org/10.1053/j.seminhematol.2013.03.004
URN:NBNurn:nbn:hr:184:013751
Publication2013
Document URLhttp://dx.doi.org/10.1053/j.seminhematol.2013.03.004
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2018-05-30 08:47:08